Representatives of Fulgent Genetics to Participate in the Piper Jaffray 31st Annual Healthcare Conference
November 25, 2019 08:00 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation...
Fulgent Genetics Announces Pricing of Public Offering of Common Stock
November 13, 2019 23:15 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “Company”), a provider of comprehensive genetic testing and Next Generation...
Fulgent Genetics Announces Proposed Public Offering of Common Stock
November 13, 2019 16:01 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “Company”), a provider of comprehensive genetic testing and Next Generation...
Fulgent Genetics Reports Third Quarter 2019 Financial Results
November 04, 2019 16:05 ET
|
Fulgent Genetics, Inc.
Third Quarter 2019 Results: Record billable tests of 20,697, growing 272% year over yearRecord revenue of $10.3 million, growing 84% year over yearGross Margin improves 8.9 percentage points year...
Fulgent Genetics to Announce Third Quarter 2019 Financial Results on Monday November 4, 2019
October 15, 2019 08:00 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Oct. 15, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its third quarter 2019...
Fulgent Genetics Launches Picture Genetics, a Consumer-Initiated Genetic Testing Offering
September 16, 2019 08:00 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation...
Fulgent Genetics Reports Second Quarter 2019 Financial Results
August 05, 2019 16:05 ET
|
Fulgent Genetics, Inc.
Second Quarter 2019 Results: Record billable tests of 16,369, growing 187% year over yearRecord revenue of $8.4 million, growing 56% year over yearGross Margin improves more than 12 percentage points...
Fulgent Genetics Names Linda Marsh to Board of Directors
August 05, 2019 08:00 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics”, “Fulgent” or the “company”) today announced the addition of Linda Marsh, Senior...
Fulgent Genetics Receives Laboratory Permit and Genetic Test Approval from New York State Department of Health
August 01, 2019 16:15 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation...
Fulgent Genetics to Announce Second Quarter 2019 Financial Results on Monday August 5, 2019
July 22, 2019 08:00 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., July 22, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its second quarter 2019...